Frontiers in Medicine (Jul 2023)

miR-223: a key regulator of pulmonary inflammation

  • Mingyu Shi,
  • Qianying Lu,
  • Yanmei Zhao,
  • Ziling Ding,
  • Sifan Yu,
  • Junfeng Li,
  • Mengjun Ji,
  • Haojun Fan,
  • Haojun Fan,
  • Shike Hou,
  • Shike Hou

DOI
https://doi.org/10.3389/fmed.2023.1187557
Journal volume & issue
Vol. 10

Abstract

Read online

Small noncoding RNAs, known as microRNAs (miRNAs), are vital for the regulation of diverse biological processes. miR-223, an evolutionarily conserved anti-inflammatory miRNA expressed in cells of the myeloid lineage, has been implicated in the regulation of monocyte–macrophage differentiation, proinflammatory responses, and the recruitment of neutrophils. The biological functions of this gene are regulated by its expression levels in cells or tissues. In this review, we first outline the regulatory role of miR-223 in granulocytes, macrophages, endothelial cells, epithelial cells and dendritic cells (DCs). Then, we summarize the possible role of miR-223 in chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), coronavirus disease 2019 (COVID-19) and other pulmonary inflammatory diseases to better understand the molecular regulatory networks in pulmonary inflammatory diseases.

Keywords